Panbela Announces Closing of Approximately $9.0 Million Public Offering

MINNEAPOLIS, Feb. 01, 2024 -- Panbela Therapeutics, Inc. , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today...

Related Keywords

United States ,Tammy Groene ,Nasdaq Stock Market ,Exchange Commission ,Roth Capital Partners ,Nasdaq ,European Union ,Panbela Therapeutics Inc ,Public Warrants ,Capital Partners ,Clemente Drive ,Newport Beach ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Markets ,